Kia ora

Thank you for your request for official information received on 12 April
2020 for:

 "I am writing to get a bit more information around the recommendation
made in item 8.2.1 in the Minutes of the 63rd meeting of the Medicines
Classification Committee held in Wellington on 10 October 2019 at 9:39 am.
This item refers to reclassifications of Alkyl Nitrites including Amyl
Nitrites.

I note that the recommended schedule changes to make Alkyl Nitrite a
prescription-only substance, and Amyl Nitrites a pharmacy-only substance
(although there is currently no distribution through pharmacies of either
of these), is for 'harmonisation' with similar regulations in Australia.

May I please request the following:

- A synthesis of material presented and/or made available to the committee
providing evidence to support these schedule changes

- If for some reason this does not exist, instead any communication,
correspondence, documentation, or further discussion given for or against
the following resolution made in the discussion section of 8.2.1:

The Committee recommended harmonising the group entry for alkyl nitrites a
prescription medicine.

- Any follow up communication or correspondence pertaining to the
following point in the discussion section of 8.2.1:

The Committee discussed how the indicated population are Men who have Sex
with Men (MSM) and it was not clear to the Committee what the risks were
around these substances.

- Any follow up communication, correspondence, or planning for future
engagement pertaining the following point in the discussion section of
8.2.1:

The Committee was also not sure if the LGBTQI community was aware that
these substances were being considered by reclassification and suggested
that feedback from them should be sought.

This final point is of specific importance as it seems that feedback from
the LGBTQI community was not sought prior to the schedule changes coming
into effect in February 2020."

The Ministry's reference number for your request is: H202002084.

As required under the Act we will endeavour to respond to your request no
later than 12 May 2020, being 20 working days after the day your request
was received.  

If we are unable to respond to your request within this time frame, we
will notify you of an extension of that time frame.

If you have any queries related to this request, please do not hesitate to
get in touch.

Please note, due to the emergence of Covid-19 the Ministry has diverted
significant resources to responding to the pandemic. This may impact on
our ability to respond to your request. If you would like to reconsider or
refine your current request, this may enable us to respond more quickly.
You can notify us of any changes to your request by responding to this
email.

Ngā mihi

OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [email address]

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

hide quoted sections

Kia ora S Mills

Please find attached a response to your request for official information
along with the relevant supporting documents.

Nga mihi

OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [email address]

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

hide quoted sections